Type II diabetes (T2D) and pre-diabetes, also known as metabolic disease, affects nearly 100 million Americans (1 in 3 people).
Treatment costs exceed $322 billion per year.
20% of all healthcare dollars are spent on metabolic disease.
Most estimates of diabetes in this report do not differentiate between type 1 and type 2 diabetes. However, because type 2 diabetes accounts for 90% to 95% of all diabetes cases, the data presented are likely to be more characteristic of type 2 diabetes.